LON:DNL - Diurnal Group Stock Price, Price Target & More

GBX 195 0.00 (0.00 %)
(As of 04/25/2018 04:00 PM ET)
Previous CloseGBX 195
Today's RangeGBX 194 - GBX 194
52-Week RangeGBX 118 - GBX 215.80
Volume45 shs
Average Volume7,428 shs
Market Capitalization£160.17 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Diurnal Group (LON:DNL)

Diurnal Group logoDiurnal Group plc is a clinical-stage pharmaceutical company. The Company is engaged in developing hormone therapeutics to aid treatment for various endocrine conditions. The Company's products include Chronocort, which is engaged in developing hydrocortisone product for the treatment of congenital adrenal hyperplasia and adrenal insufficiency; Infacort, which is engaged in creating paediatric hydrocortisone replacement product for neonates and infants suffering from adrenal insufficiency; Native Oral Testosterone, which is engaged in creating oral testosterone treatment for hypogonadism, and Tri4Combi, which is engaged in developing combination therapy product of thyroid hormones for patients suffering from hypothyroidism. The Company's products are under various clinical trials, including Chronocort, which is in Phase III clinical trial; Infacort, which is in Phase III clinical trial, and Native Oral Testosterone, which is in Phase I clinical trial.

Receive DNL News and Ratings via Email

Sign-up to receive the latest news and ratings for DNL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolLON:DNL
CUSIPN/A
Phone+44-29-20682069

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on Equity-39.52%
Return on Assets-29.56%

Miscellaneous

EmployeesN/A
Outstanding Shares52,320,000

How to Become a New Pot Stock Millionaire

Diurnal Group (LON:DNL) Frequently Asked Questions

What is Diurnal Group's stock symbol?

Diurnal Group trades on the London Stock Exchange (LON) under the ticker symbol "DNL."

How were Diurnal Group's earnings last quarter?

Diurnal Group (LON:DNL) released its quarterly earnings results on Monday, March, 12th. The company reported ($12.70) earnings per share (EPS) for the quarter. View Diurnal Group's Earnings History.

What price target have analysts set for DNL?

2 brokers have issued twelve-month price targets for Diurnal Group's stock. Their forecasts range from GBX 178 to GBX 185. On average, they expect Diurnal Group's share price to reach GBX 181.50 in the next twelve months. View Analyst Ratings for Diurnal Group.

Who are Diurnal Group's key executives?

Diurnal Group's management team includes the folowing people:
  • Martin Whitaker Ph.D., Chief Executive Officer, Executive Director
  • Richard Edward Bungay, Chief Financial Officer (Age 47)
  • Richard Ross, Chief Scientific Officer, Director
  • David Eckland, Medical Director
  • Hiep Huatan Ph.D., Chief Development Offer
  • Daniel Nelson Margetson, CMC Director
  • John Porter, Medical Affairs Director
  • Michael Withe, Commercial Director
  • Peter Vance Allen, Non-Executive Chairman of the Board (Age 58)
  • Alan Michael Raymond Ph.D., Non-Executive Director

Has Diurnal Group been receiving favorable news coverage?

News articles about DNL stock have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies negative and positive media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Diurnal Group earned a media sentiment score of 0.21 on Accern's scale. They also gave headlines about the company an impact score of 45.41 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

How do I buy shares of Diurnal Group?

Shares of DNL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Diurnal Group's stock price today?

One share of DNL stock can currently be purchased for approximately GBX 195.

How big of a company is Diurnal Group?

Diurnal Group has a market capitalization of £160.17 million.

How can I contact Diurnal Group?

Diurnal Group's mailing address is Heath Park, CARDIFF, CF14 4UJ, United Kingdom. The company can be reached via phone at +44-29-20682069.


MarketBeat Community Rating for Diurnal Group (DNL)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  107 (Vote Outperform)
Underperform Votes:  63 (Vote Underperform)
Total Votes:  170
MarketBeat's community ratings are surveys of what our community members think about Diurnal Group and other stocks. Vote "Outperform" if you believe DNL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DNL will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Diurnal Group (LON:DNL) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Diurnal Group in the last 12 months. Their average twelve-month price target is GBX 181.50The high price target for DNL is GBX 185 and the low price target for DNL is GBX 178. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 181.50GBX 181.50GBX 181.50GBX 173.50

Diurnal Group (LON:DNL) Consensus Price Target History

Price Target History for Diurnal Group (LON:DNL)

Diurnal Group (LON:DNL) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
2/13/2018Numis SecuritiesReiterated RatingBuyGBX 185View Rating Details
6/15/2017Panmure GordonReiterated RatingBuyGBX 178View Rating Details
(Data available from 4/25/2016 forward)

Earnings

Diurnal Group (LON:DNL) Earnings History and Estimates Chart

Earnings by Quarter for Diurnal Group (LON:DNL)

Diurnal Group (LON DNL) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/12/2018S1 2018GBX (12.70)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Diurnal Group (LON:DNL) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Diurnal Group (LON DNL) Insider Trading and Institutional Ownership History

Insider Trading History for Diurnal Group (LON:DNL)

Diurnal Group (LON DNL) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/5/2018John GoddardInsiderBuy10,791GBX 540£58,271.40
11/27/2017Martin WhitakerInsiderBuy3,703GBX 135£4,999.05
11/8/2017Martin WhitakerInsiderSell33,650GBX 135£45,427.50
9/7/2017John GoddardInsiderBuy10,791GBX 5£539.55
1/16/2017Alan RaymondInsiderBuy9,000GBX 110£9,900
1/13/2017Sam WilliamsInsiderBuy9,248GBX 108£9,987.84
(Data available from 1/1/2013 forward)

Headlines

Diurnal Group (LON DNL) News Headlines

Source:
DateHeadline
Appointment of CRO to support US Chronocort trials - London South East (blog)Appointment of CRO to support US Chronocort trials - London South East (blog)
www.lse.co.uk - March 13 at 5:31 PM
UPDATE: Diurnal Prepares For First Revenue As Appoints Trial PartnerUPDATE: Diurnal Prepares For First Revenue As Appoints Trial Partner
www.morningstar.co.uk - March 12 at 4:39 PM
BRIEF-Diurnal Group Says ‍HY Operating Loss Of 7.7 Mln StgBRIEF-Diurnal Group Says ‍HY Operating Loss Of 7.7 Mln Stg
www.reuters.com - March 12 at 4:39 PM
Diurnal Group (DNL) Issues  Earnings ResultsDiurnal Group (DNL) Issues Earnings Results
www.americanbankingnews.com - March 12 at 7:16 AM
Diurnal Group plc (LON:DNL): Are Analysts Bull Or Bear?Diurnal Group plc (LON:DNL): Are Analysts Bull Or Bear?
finance.yahoo.com - March 6 at 10:18 AM
Diurnal Group Granted First Alkindi And Chronocort Patents In JapanDiurnal Group Granted First Alkindi And Chronocort Patents In Japan
www.morningstar.co.uk - February 22 at 4:11 PM
Diurnal Group Signs Australia And New Zealand Therapies AgreementDiurnal Group Signs Australia And New Zealand Therapies Agreement
www.morningstar.co.uk - February 19 at 9:39 AM
Diurnal Groups (DNL) Buy Rating Reiterated at Numis SecuritiesDiurnal Group's (DNL) Buy Rating Reiterated at Numis Securities
www.americanbankingnews.com - February 19 at 12:34 AM
Diurnal Enrols Patients For Pivotal Chronocort Clinical TrialDiurnal Enrols Patients For Pivotal Chronocort Clinical Trial
www.morningstar.co.uk - February 12 at 5:10 PM
Diurnal Group PLC (DNL) Insider Acquires £58,271.40 in StockDiurnal Group PLC (DNL) Insider Acquires £58,271.40 in Stock
www.americanbankingnews.com - January 5 at 3:14 PM
Diurnal Group (DNL) Receives Buy Rating from Numis SecuritiesDiurnal Group (DNL) Receives Buy Rating from Numis Securities
www.americanbankingnews.com - December 19 at 12:38 AM
Insider Buying: Diurnal Group PLC (DNL) Insider Buys 3,703 Shares of StockInsider Buying: Diurnal Group PLC (DNL) Insider Buys 3,703 Shares of Stock
www.americanbankingnews.com - November 29 at 10:30 AM
Diurnal Group PLC (DNL) Insider Martin Whitaker Sells 33,650 SharesDiurnal Group PLC (DNL) Insider Martin Whitaker Sells 33,650 Shares
www.americanbankingnews.com - November 14 at 1:28 AM
Diurnal Group PLCs (DNL) "Buy" Rating Reiterated at Numis Securities LtdDiurnal Group PLC's (DNL) "Buy" Rating Reiterated at Numis Securities Ltd
www.americanbankingnews.com - September 10 at 10:44 PM
Insider Buying: Diurnal Group PLC (DNL) Insider Purchases 10,791 Shares of StockInsider Buying: Diurnal Group PLC (DNL) Insider Purchases 10,791 Shares of Stock
www.americanbankingnews.com - September 8 at 7:16 AM
Half Year 2017 Diurnal Group PLC Earnings Release - Time Not SuppliedHalf Year 2017 Diurnal Group PLC Earnings Release - Time Not Supplied
biz.yahoo.com - March 20 at 7:48 PM
Submission of Infacort   European PUMA Application - London South East (registration) (blog)Submission of Infacort European PUMA Application - London South East (registration) (blog)
www.lse.co.uk - December 20 at 10:44 PM
Full Year 2016 Diurnal Group PLC Earnings Release - Time Not SuppliedFull Year 2016 Diurnal Group PLC Earnings Release - Time Not Supplied
biz.yahoo.com - October 12 at 9:31 AM
Half Year 2016 Diurnal Group PLC Earnings Release - Time Not SuppliedHalf Year 2016 Diurnal Group PLC Earnings Release - Time Not Supplied
biz.yahoo.com - March 30 at 7:07 AM

SEC Filings

Diurnal Group (LON:DNL) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Diurnal Group (LON DNL) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.